急性心肌梗死患者静脉溶栓对QTd的影响及其临床意义

【目的】探讨急性心肌梗死（AMI）患者静脉溶栓对QT离散度（QTd）的影响,并评价其与近期恶性室性心律失常的相关性。【方法】将158例AMI静脉溶栓的患者分为再通组和未再通组,比较溶栓前、溶栓后24h的QTd变化,同时观察两组患者溶栓治疗后一周内恶性室性心律失常的发生情况,分析其与QTd的相关性。【结果】静脉溶栓再通组QTd明显减少（P〈0．01）,未再通组无明显变化（P〉0．05）;再通组恶性室性心律失常发生率明显低于未再通组（12．7％比32．1％,P〈0．01）。AMI伴恶性室性心律失常者的QTd明显大于无恶性室性心律失常者（P〈0．01）。【结论】成功的静脉溶栓能显著减少AMI患者的QTd,降低恶性室性心律失常的发生率;QTd对判断静脉溶栓疗效、评价AMI近期预后具有一定的临床参考价值。     

溶栓治疗对急性心肌梗死患者QT离散度的影响

目的:探讨急性心肌梗死(AMI)患者静脉溶栓前后QT离散度(QTd)变化及其对预后的影响.方法:105例AMI患者分为溶栓再通组、未通组和未溶栓组.测定其溶栓前及溶栓治疗1、2周后QTd变化,并与未溶栓组比较.同时比较三组治疗2周时高危室性心律失常.结果:溶栓治疗再通治疗1、2周后QTd显著缩小(P皆＜0.01),高危室性心律失常的发生率低,其与未通组和未溶栓组比较,差异皆有显著性(P＜0.01).而未通组、未溶栓组治疗前后QTd变化和高危室性心律失常的发生率皆无差异(P＜0.05).结论:AMI后2周内QTd增大者,其溶栓再通的可能性小,发生高危室性心律失常的可能性增大.     

早期溶栓治疗对急性心肌梗死患者QT间期离散度的影响

目的 :探讨早期溶栓治疗对急性心肌梗死患者QT间期离散度的影响。方法 :116例AMI患者 ,溶栓再通组 3 6例 ,未通组 16例 ,非溶栓组 64例 ,比较 3组QTd。结果 :溶栓再通组QTd值明显减少 ,未通组及非溶栓组QTd值增大 ,且后两组QTd值比较差异无显著性 (P >0 0 5 )。QTd增大者发生室性快速心律失常比率增大。结论 :溶栓再通后AMI患者QTd值明显降低 ,同时室性快速心律失常发生率降低     

急性心肌梗死患者溶栓前后QT离散度的变化

目的:观察急性心肌梗死(AMI)患者溶栓前后QT离散度(QTdispersion,QTd)的变化及早期再灌注对QTd的影响。方法:对61例AMI患者给予尿激酶静脉溶栓治疗,予溶栓前及溶栓2h后同步记录18导联心电图,分别测量成功组及失败组的QTd,并进行前后比较。结果:溶栓后再通41例,溶栓后未通20例。血管未通组其QTd较前减少,但无统计学意义(P>0.05),溶栓后再通组其QTd较血管未通组降低程度更大,有统计学意义(P<0.01)。结论:QTd可作为评价AMI患者溶栓后判断溶栓成功与否的一项临床早期参考指标。     

急诊静脉溶栓治疗对老年急性心肌梗死QTd和CVA的影响

[目的]观察尿激酶溶栓治疗对老年急性心肌梗死（AMI）QT离散度（QTd）和复杂室性心律失常（CVA）的影响。[方法]对55例老年AMI患者在发病6h内予以尿激酶溶栓治疗,比较AMI溶栓再通组与溶栓非再通组治疗前后QTd和QT离散度校正值（QTcd）以及两组溶栓前和溶栓治疗后7d内CVA事件发生率。[结果]AMI溶栓再通组治疗7d后QTd和QTcd较非再通组显著减少（P〈0．05）,非再通组治疗前后QTd、QTed相比较差异无统计学意义（P〉0．05）。再通组CVA事件的发生率亦显著低于溶栓非再通组（P〈0．05）,非再通组治疗前后CVA的发生率差异无统计学意义（P〉0．05）。[结论]尿激酶溶栓治疗可减小AMI患者的QTd或QTcd,减少CVA的发生;QTd或QTcd可作为观察溶栓和再灌注效果的一个有效指标。     

急性心肌梗死静脉溶栓治疗对QT离散度的影响

目的 :探讨急性心肌梗死溶栓治疗对QT离散度及近期预后的影响。方法 :观察急性心肌梗死发病 12h内接受静脉溶栓治疗的 78例患者 ,按溶栓后冠脉有无再通分为再通组 (5 0例 )和未再通组 (2 8例 ) ,测定溶栓治疗前后QT离散度 (QTd)、校正的QT离散度 (QTcd) ,并观察两组恶性室性心律失常的发生情况。结果 :溶栓前两组Q T离散度无差异 ,溶栓后QT离散度再通组明显低于未再通组 (P <0 0 5 ) ,恶性室性心律失常溶栓前再通组与未再通组差异无显著意义 (P >0 0 5 ) ,溶栓后再通组显著低于未再通组 (P <0 0 1)。结论 :急性心肌梗死行有效的静脉溶栓治疗可缩短QTd、QTcd ,改善心肌电稳定性 ,并减少恶性室性心律失常的发生。     

直接和择期PTCA对AMI患者QTd和QTcd的不同影响

目的 :对照观察直接PTCA和择期PTCA对急性心肌梗死 (AMI)患者QTd和QTcd的不同影响。方法 :对 3 6例直接PTCA使病变血管血流达TIMI3级的AMI患者 ,测量其术量、术后 2h、48h12导联心电图的QTd和QTcd ,并与 48例择期PTCA的AMI患者比较。同时与 5 0例冠状动脉造影正常者对照。结果 :AMI患者QTd和QTcd对照正常组有显著差异 ,有室性心律失常的AMI患者QTd和QTcd明显高于无室性心律失常的患者 (P <0 0 5 ) ,直接PTCA和择期PTCA两组AMI患者与正常对照组QTd和QTcd均有显著性差异 ,两者的QTd和QTcd均有明显的下降 ,但前者下降的幅度远远大于后者 ,两者差异显著 ,有统计学意义。结论 :AMI患者不论直接PTCA和择期PTCA均可降低患者QTd和QTcd ,以减少心律失常的发生 ,但直接PTCA明显优于择期PTCA。     

磷酸肌酸钠对急性心肌梗死后室性心律失常的影响

目的探讨磷酸肌酸钠对急性心肌梗死（AMI）后室性心律失常的影响,为临床治疗提供依据。方法选择2012年1月至2012年11月住院的AMI患者112例,随机分为两组,各56例。所有患者均给予AMI常规治疗（抗血小板、抗凝、他汀类药物、β受体阻滞剂、血管紧张素转化酶抑制剂、硝酸酯类药物）,有适应证者应用尿激酶溶栓。治疗组在此基础上静脉应用磷酸肌酸钠。观察治疗期间两组患者室性心律失常的发生情况及治疗前后QT间期离散度（QTd）和校正的QT间期离散度（QTcd）的变化。结果治疗组频发室早、短阵室速、持续性室速和室颤发生率均稍低于对照组,但差异无统计学意义（P均﹥0.05）。两组治疗后QTd和QTcd均低于治疗前（P均〈0.05）。治疗组治疗后QTd和QTcd为（64.17±4.14）ms及（71.33±6.52）ms,低于对照组治疗后的（71.30±5.22）ms及（77.82±7.65）ms,差异具有统计学意义（P均〈0.05）。结论磷酸肌酸钠可使AMI患者QTd和QTcd显著降低,能否确实减少AMI后室性心律失常的发生,有待扩大样本量进一步观察。     

急性心肌梗死患者QT离散度与室性心律失常的关系

目的探讨急性心肌梗死(AMI)患者QT间期离散度(QTd)与室性心律失常的关系。方法测量42例AMI患者心电图的QTd,对有室性心律失常组与无室性心律失常组进行比较。结果AMI有室性心律失常组的QTd高于无室性心律失常组的QTd。结论AMI患者发生室性心律失常与QTd增大有关。     

56例扩张型心肌病患者QT离散度变化

目的:探讨扩张型心肌病(DCM)QT离散度(QTd)与恶性室性心律失常的关系。方法:选择32例恶性室性心律失常DCM,24例非恶性室性心律失常DCM和43例非心脏疾病患者,测定QTd,QTcd。结果:DCM恶性室性心律失常组及非恶性室性心律失常组QTd,QTcd明显高于对照组(P<0.05);DCM恶性室性心律失常组QTd,QTcd明显高于非恶性室性心律失常组。结论:QTd及QTcd可能是DCM恶性室性心律失常的监测指标。     

Ischaemic preconditioning attenuates haemodynamic response and lipid peroxidation in lower-extremity surgery with unilateral pneumatic tourniquet application: A clinical pilot study

INTRODUCTION: THE HARMFUL EFFECTS OF ISCHAEMIA-REPERFUSION ON SKELETAL MUSCLE DURING EXTREMITY SURGERY CAN BE DIMINISHED BY USING MEDICATIONS OR ISCHAEMIC PRECONDITIONING: METHODS: TWENTY PATIENTS UNDERGOING LOWER-LIMB SURGERY WITH USE OF A TOURNIQUET FOR AT LEAST 1 HOUR WERE INCLUDED IN THE STUDY AND RANDOMISED INTO TWO GROUPS: A CONTROL GROUP WITH ONLY TOURNIQUET APPLICATION (T GROUP; N=10); AND AN ISCHAEMIC PRECONDITIONING PLUS TOURNIQUET GROUP (IP-T GROUP; N=10). BLOOD SAMPLES WERE OBTAINED FROM THE FEMORAL VEIN OF THE RELEVANT EXTREMITY BEFORE TOURNIQUET APPLICATION (BASELINE), IMMEDIATELY AFTER TOURNIQUET DEFLATION (TD), AT 10 MINUTES AFTER THE TOURNIQUET DEFLATION (TD10MIN) IN THE T GROUP AND ADDITIONALLY AFTER ISCHAEMIC PRECONDITIONING IN THE IP-T GROUP. VENOUS BLOOD PH, PARTIAL OXYGEN PRESSURE (PVO2), PARTIAL CARBON DIOXIDE PRESSURE (PVCO2), LACTATE, POTASSIUM, SODIUM AND GLUCOSE LEVELS WERE ANALYSED USING A BLOOD GAS ANALYSER. PLASMA THIOBARBITURIC ACID REACTIVE SUBSTANCES (TBARS) LEVEL, AN INDEX OF LIPID PEROXIDATION AND OXIDATIVE STRESS, WAS MEASURED. HEART RATE, NONINVASIVE MEAN ARTERIAL PRESSURE (MAP) AND SPONTANEOUS BREATHING RATE (SBR) WERE RECORDED AT BASELINE, AT TD, AND TD1MIN, TD5MIN AND TD10MIN : RESULTS: MAP DECREASED AND SBR INCREASED SIGNIFICANTLY AT TD, TD1MIN AND TD5MIN COMPARED WITH BASELINE, AND VENOUS BLOOD TBARS LEVEL SIGNIFICANTLY INCREASED AT TD AND TD10MIN COMPARED WITH BASELINE IN THE T GROUP (ALL P<0.05). NO SIGNIFICANT CHANGES WERE OBSERVED IN THE IP-T GROUP. ISCHAEMIC PRECONDITIONING CAUSED A RISE IN PVO2 AND A DECREASE IN VENOUS BLOOD PH, PVCO2, AND LACTATE LEVELS, WHICH WAS SIGNIFICANT COMPARED WITH BASELINE (P<0.05): CONCLUSION: ISCHAEMIC PRECONDITIONING ATTENUATES HAEMODYNAMIC RESPONSE AND LIPID PEROXIDATION DURING LOWER-EXTREMITY SURGERY WITH UNILATERAL TOURNIQUET APPLICATION:     

心肺复苏时紧急经静脉临时心脏起搏的临床疗效分析

目的探讨应用紧急经静脉临时心脏起搏对心肺复苏(CPR)成功率及出院率的影响。方法回顾性分析院内常规组和起搏组CPR病人的临床资料。结果常规组和起搏组间年龄、性别、心肺复苏所需时间、复苏成功率及出院率在统计学上无明显差异,右颈内静脉穿刺所用时间较锁骨下静脉及股静脉耗时显著减少(P<0.05);两组循环维持时间有显著性差异(P<0.05)。结论紧急经静脉临时心脏起搏对维持循环稳定有帮助,以右颈内静脉置入更佳,但对CPR成功率及出院率的影响不大。     

65例青年人急性心肌梗死冠状动脉造影与临床思考

目的：了解近年来青年人(40岁以下)急性心肌梗死(AMI)发病的病因和临床特点，探讨防治措施，减少病死率及致残率。方法：对65例青年人AMI患者的心电图、心肌酶学、冠状动脉造影检查及临床表现等进行回顾性分析。结果：近年来青年人AMI增多的病因以工作压力大、社会竞争激烈及不良生活习惯等诱发冠状动脉痉挛(64％，42／65)为主，而不是以冠状动脉粥样硬化(30％，19／65)为主；多无AMI先兆表现，病情急，临床症状典型，并发症少，预后良好。结论：去除不良生活习惯，减少精神紧张，可以降低青年人AMI发病率。青年人发生AMI时，冠状动脉造影既可明确病因，又是决定进一步治疗的最佳检查方法。     

急性冠周炎期智齿拔除的有效性和安全性探讨

目的：探讨急性冠周炎期智齿拔除的有效性和安全性。方法：对238例急性下颌智齿冠周炎采用初期即时拔牙法，观察并记录局部疼痛、肿胀、张口程度和拔牙创口愈合情况。结果：术后第3天复诊，局部疼痛、肿胀明显著减缓退减轻者220例(92．4％)；术后第7天复诊局部疼痛、肿胀消退者228(95．8％)例，张口度正常，拔牙创愈合良好。无发热、头痛等炎症扩散的全身并发症出现。结论：急性智齿冠周炎初期，即时拔除下颌阻生智齿可以作为一种有效的选择。     

急诊内镜在肝硬化上消化道出血中的应用价值(附116例报道)

目的：分析门静脉高压时上消化道出血原因，了解胃粘膜的改变，评价急诊内镜检查的价值。方法：回顾性分析了116例肝硬化门静脉高压合并急性上消化道出血患者行急诊内镜检查的临床资料。结果：116例患者中，Ⅲ度食管静脉曲张76例，合并反流性食管炎15例(12．4％)，胃十二指肠溃疡24例(19．0％)．急性胃粘膜病变29例(25％)。102例(87．9％)镜下见到出血灶，其中见静脉曲张破裂出血84例(82．3％)。非静脉曲张破裂出血18例(17．7％)。14例(12．1％)未发现明确出血原因。40例行胃粘膜活检，病理结果均提示门静脉高压性胃病。结论：肝硬化门静脉高压患者出现上消化道出血时，行急诊内镜检查是安全的，应积极行急诊内镜检查以明确出血原因。指导临床治疗。     

急性胃扩张的诊治体会及认识的重要性(附2例报告)

急性胃扩张是一种少见疾病，是由于各种原因导致胃的麻痹、胃内压急剧升高及胃血液动力性改变最终引起胃的过度膨胀。由胃内压升高导致胃壁血管功障碍是急性胃扩张发病的关键因素．胃腔过度膨胀所致胃壁坏死穿孔是急性胃扩张最严重的并发症，其死亡率极高。本文报道2例原因不明的急性胃扩张伴胃壁坏死破裂并进行相关文献综述。     

酒精性肝病合并弧菌性脓毒症的临床及病理学特点

目的：探讨酒精性肝病合并弧菌性脓毒症患者的临床病理特点。方法：自2002年8月至2004年8月问符合酒精性肝病合并弧菌性脓毒症早期临床诊断主要依据的患者6例，在应用抗菌药物、补液扩容、升压及1～2h内切开患肢以减压、引流、清创等外科治疗，在总结其临床特点同时，观察患者下肢的临床病理特点及超微结构改变。结果：患者首先出现下肢足背或小腿肿胀、剧烈疼痛、局部红斑、数小时内血疱增多、融合成大血疱、皮肤大片淤血斑，下肢病变迅速扩大并向大腿或躯体蔓延，患者同时出现休克、MODS表现。2例下肢皮肤苍白、肌肉色红。肌酸磷酸激酶(CPK)正常或轻度升高，经清创、植皮后保存了患肢。另4例见皮肤脂肪坏死，筋膜肌肉坏死范围广．小血管血栓形成，患者的CPK明显升高，其中2例下肢病变严重，行截去患肢治疗，2例切开患肢以减压、引流、清创等病情好转，因经济原因放弃进一步治疗。6例中4例患者治愈出院。作者通过光镜及电镜对弧菌感染患者下肢病变组织系统观察，包括皮肤、肌肉、脂肪、坐骨神经、股动脉、股静脉，结合大体表现发现创伤弧菌脓毒症患者下肢病变组织病理改变主要表现为炎症性改变。结论：及早正确认识下肢临床及病理改变特点对早期临床诊断及治疗十分重要，可有效提高患者生存率。     

A37 REACTIVITY OF PLATELET AUTOANTIBODIES WITH PAPAIN TREATED PLATELETS AND COMPARISON WITH GLYCOPROTEIN SPECIFICITY.

A1 INFLUENCE OF POSTURE ON REACTIONS IN NEW BLOOD DONORS. A2 A CONFIDENTIAL UNIT EXCLUSION SYSTEM IDENTIFIES DONORS WITH A POTENTIAL FOR HIV INFECTION. A3 A STABLE BLOOD SUPPLY FOR THE FUTURE: THE RECRUITMENT OF 16 TO 18 YEAR OLD DONORS TODAY AND THEI CONTRIBUTION AS COMMITTED REGULAR DONORS OF TOMORROW. A4 APPROACH TO A SUPPLY CRISIS OF HYPERIMMUNE RHESUS PLASMA FOR THE PRODUCTION OF RhD IMMUNOGLOBULIN A5 THE INFLUENCE OF AGE, SEX AND ABO BLOOD GROUP ON THE INCIDENCE OF CMV ANTIBODIES IN SYDNEY BLOOD DONORS. A6 THE INCIDENCE OF CATEGORY VI AMONGST WEAK Rh(D) POSITIVE SYDNEY BLOOD DONORS. A7 A MODIFIED METHOD FOR DETECTING HIGH TITRE ANTI-A AND ANTI-B IN GROUP O DONORS A8 IMPROVING THE CLINICAL SPECIFICITY OF ALANINE AMINO TRANSFERASE (ALT) TEST RESULTS WITHIN THE NORMAL BLOOD DONOR POPULATION OF QUEENSLAND. A9 EXTRACTION OF HCV RNA USING A GUANIDINE ISOTHIOCYNATE METHOD. A10 HEPATITIS C VIRUS (HCV) ANTIBODY DETECTION IN TASMANIAN BLOOD DONORS. A11 EFFECTIVE INTERNAL QUALITY CONTROL FOR ENZYME IMMUNOASSAYS A12 DETECTION OF ANTIBODY TO NON-PATHOGENIC RETROVIRUSES (SPUMAVIRUSES) IN HUMAN SERUM A13 DETECTION OF ANTIBODY TO NON-PATHOGENIC RETROVIRUSES (SPUMAVIRUSES) IN HUMAN SERUM A14 A NOVEL BLOOD BAG SYSTEM WITH POTENTIAL, FOR THE ASIA-PACIFIC MARKET. A15 DESIGN OF CONTAINERS SUITABLE FOR THE TRANSPORT OF RED CELL, PLATELET AND FROZEN PLASMA PRODUCTS. A16 EVALUATION OF INDICATOR LABELS FOR QUALITY ASSURANCE OF IRRADIATION PROCEDURE OF BLOOD PRODUCTS. A17 MOLECULAR TYPING FOR UNUSUAL ABO TYPES. A18 AN EXAMPLE OF THE RARE ABO SUBGROUP, A19 RFLP ANALYSIS OF A RH NULL BLOOD DONOR. A20 A RELATIONSHIP BETWEEN LEWIS ERYTHROCYTE PHENOTYPES AND COLORECTAL CANCER. A21 PATERNITY TESTING USING SINGLE LOCUS DNA PROBES: OBSERVATIONS ON THE REFERENCE DATA BASE SIZE A22 USE OF FAMILY AND POPULATION STUDIES TO DETERMINE THE SPECIFICITY AND INHERITANCE OF NEUTROPHIL ANTIGENS DEFINED BY PLANT LECTINS. A23 SAMPLING PLANS: IS THERE RELEVANCE FOR BLOOD COMPONENT QC? A24 QUALITY MANAGEMENT: HOW DO WE DO IT IN A STATE THE SIZE OF QUEENSLAND? A26 THE ENERGY METABOLISM OF CIRCULATING CELLS. A27 ACETATE UTILISATION RATES AND THE EFFECT OF GLUCOSE-FREE PLASMA IN PLATELET CONCENTRATE STORED IN A MIMIMAL MEDIUM (MPM). A28 IMPROVED LEVELS OF 2,3 DJPHOSPHOGLYCERATE IN RED CELL SUSPENSIONS PREPARED FROM BLOOD COLLECTED INTO DEXTROSE-FREE ANTICOAGULANT. A29 EVALUATION OF RED CELL FREEZING METHODS AS A PRELUDE TO ADOPTING -80° C FREEZING IN HIGH GLYCEROL IN ROUTINE PRACTICE. A30 CLUMPING IN PLATELET CONCENTRATES - AN UNSOLVED PROBLEM. A31 AUTOLOGOUS BLOOD: SAFE FOR OTHERS OR NOT? A32 ESTABLISHMENT OF AN AUSTRALIAN HAEMOPHILIA TREATMENT CENTRE DATA BANK. A33 EXPERIENCE IN THE USE OF ROBOTICS AND MICROPLATE TECHNOLOGY TO SEMI-AUTOMATE A ROUTINE HOSPITAL BLOOD BANK. A34 AN ANTI-IgAl/IgA2 ELISA ASSAY FOR THE INVESTIGATION OF HYPESENSITIVITY TRANSFUSION REACTIONS. A35 THE INFLUENCE OF IgG AGGREGATES AND FRESH NORMAL SERUM ON THE MONOCYTE MONOLAYER ASSAY A36 DETECTION OF Rh(D) POSITIVE FETAL CELLS IN PREGNANT Rh(D)-NEGATIVE WOMEN BY FLOW CYTOMETRY. A38 HAEMOSTAT-IX: A HIGH PURITY FACTOR CONCENTRATE FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA B. A39 GRAVITY FILTRATION OF PLASMA FROM DONOR BLOOD UTILISING A HOLLOW FIBRE FILTER MEMBRANE DEVICE A40 The Therapeutic Device Problem Reporting Scheme, and the Victorian Red Cross Blood Bank A43 HIGH FREQUENCY ANTIBODIES AND THE ADVANTAGES OF MANUAL POLYBRENE. A44 FACTS AND FANTASY IN THE DEVELOPMENT OF PLATELET ADDITIVE SOLUTIONS. A45 LACK OF EFFECT OF STORAGE CONTAINER ON STORAGE OF PLATELETS PREPARED FROM DEXTROSE-FREE BLOOD, A46 PLATELETS PREPARED FROM DEXTROSE-FREE BLOOD MAY BE STORED WITHOUT AGITATION. A47 QUALITY OF BED CELL CONCENTRATE IN HOSPITALS COMPARED TO THE BLOOD BANK A48FLOW CYTOMETRIC CHARACTERISATION OF LEUCOCYTE - DEPLETED RED CELL CONCEHTRATES. A49 PRODUCTION AND CHARACTERISATION OF HUMAN MONOCLONAL ANTI-D ANTIBODIES. A50 CD55 AND CD59 SUSCEPTIBILITY TO PROTEASE TREATMENT AND THE RESULTANT EFFECT ON COMPLEMENT LYSIS OF RBCs. A51 DIRECT COMPARISON BETWEEN PLATELET STORAGE CONTAINERS - IMPROVEMENT IN STORAGE CHARACTERISTICS OF TUTA PLATELET BAGS OVER THE PAST FOUR YEARS. A52 IMPROVED SOLID-PHASE MIXED PASSIVE HAENAGGLUTININ ASSAY (MPHA) WITH FROZEN PANEL PLATELETS FOR THE DETECTION OF HUMAN PLATELET ANTIBODIES. A53 DEVELOPMENT OF A SOLVENT DETERGENT TREATED THROMBIN CONCENTRATE AS A COMPONENT OF A FIBRIN GLUE KIT. A54 Autologous blood transfusion: a promotional programme A55 AVAILABILITY OF BLOOD PRODUCTS FOR ACUTELY BLEEDING PATIENTS. A56 REMINISCENCES OF 50 YEARS A. A TRANSFUSION ST. A57 A NATIONAL SYSTEM FOR REPORTING TRANSFUSION REACTIONS TO FRACTIONATED BLOOD PRODUCTS. A58 EFFECT OF FLUORESCENT LIGHTING ON THE VISUAL APPEARANCE OF PLATELET CONCENTRATES A59 USING A MICROWAVE OVEN TO THAW FRESH FROZEN PLASMA. A60 COAGULATION CAPACITY OF POOLED PLATELET PLASMA. A61 A COMPARISON OF IMMUNOHAEMATOLOGY SURVEY PERFORMANCE BETWEEN NEK ZEALAND AND AUSTRALIA A62 COMPATIBILITY TESTING: ARE ENZYME TESTS REQUIRED? A63 AN EVALUATION OF THE DIAMED MEROTYPING SYSTEM FOR THE PERFORMANCE OF THE DIRKT ANTIGLOBUDIN TEST. A64 ASSESSMENT OF PERFORMANCE IN BLOOD GROUP ANTIBODY DETECTION. A65 CHARACTERISATION OF MABS TO THROMBIN-HIRUDIN COMPLEXES WITH IMMUNOASSAY POTENTIAL. A66 MONITORING ANTT-HPA-la (P1^A1) PLATELET ANTIBODY LEVELS DURING PREGNANCY USING THE MAIPA TEST. A67 COMPARISON OF PIFT AND MAIPA TEST“ IN THE DETECTION OF ANTI-HPA-la (PI^A1) PLATELET ANTIBODIES. A68 USE OF PLATELET-CROSSMATCHING IN SUPPORT OF A CASE OF MYELODYSPLASIA WTTH A PLATELET SPECIFIC AND B LYMPHOCYTE ANTIBODY A69 The Pattern of Leucocyte Antibody formation in Transfused Patients. A70 DETECTION OF HPA-Ia ANTIBODY IN BREAST MILK A71 ANALYSIS OF PRENATAL SCREENING. A72 DETECTION OF MINOR POPULATIONS OF ERYTHROCYTES A73 MODIFICATIONS TO THE MCNOCYTE-MEDIATED ADCC ASSAY. A74 AN AUTO ANTI-JMH; GAMMA-CLONE POLYSPECIFIC AHG AS A USEFUL TOOL. A75 CLINICALLY SIGNIFICANT ANTI-A1 DERIVED FROM B LYMPHOCYTES FOLLOWING SINGLE LUNG TRANSPLANTATION. A76 CONFIRMATION THAT ANTI-ELO CAUSES HAEMOLYTIC DISEASE OFTHE NEWBORN. A77 ANTI-Do^a STIMULATED BY PREGNANCY. A78 DONOR IgM ANTI-A ASSOCIATED WITH HAEMOLYTIC TRANSFUSION REACTION A79 COLLECTION OF GRANULOCYTES AND PLATELETS USING FENWALL CS 3000 AND HAEMONETICS 30 CELL SEPARATORS - A COMPARISON. A80 APPARENT LYMPHOPENIA IN PLASMAPHERESIS DONORS     

全层缝合在预防阑尾炎术后切口感染中的应用

目的：探讨全层缝合在预防阑尾炎术后切口感染的治疗效果。方法：将皮肤、皮下组织、腹外斜肌腱膜全层褥式缝合(腹膜不予缝合)。结果：56例患者无一例感染，也未发现近期并发症。结论：此方法对预防切口感染有较好疗效，且能缩短手术时间，操作简单，建议值得临床应用。     

延迟性脾破裂的诊断和治疗

目的：探讨延迟性脾破裂(DRS)的诊断和治疗方法。方法：回顾性分析1993年2月至2004年1月收治的16例延迟性脾破裂病人的临床资料。结果：延迟性脾破裂由于发病率不高，临床表现不典型，易被误诊。本组病人11例行脾切除术，4例脾部分切除术，1例行保守治疗，无手术死亡。结论：外伤史、腹部B超、CT及诊断性腹腔穿刺是延迟性脾破裂诊断的重要手段；脾切除术是主要治疗方法。